KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsBuildingsCash & Current InvestmentsCash & EquivalentsCommon EquityConstruction in ProgressCurrent AssetsCurrent LeasesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLiabilities from Discontinued OperationsLong-Term Deferred TaxLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Edwards Lifesciences (EW) Current Assets (2016 - 2025)

Edwards Lifesciences (EW) has 17 years of Current Assets data on record, last reported at $6.7 billion in Q4 2025.

  • For Q4 2025, Current Assets rose 7.22% year-over-year to $6.7 billion; the TTM value through Dec 2025 reached $6.7 billion, up 7.22%, while the annual FY2025 figure was $6.7 billion, 7.22% up from the prior year.
  • Current Assets reached $6.7 billion in Q4 2025 per EW's latest filing, up from $6.4 billion in the prior quarter.
  • Across five years, Current Assets topped out at $6.7 billion in Q4 2025 and bottomed at $3.1 billion in Q1 2021.
  • Average Current Assets over 5 years is $4.4 billion, with a median of $3.8 billion recorded in 2023.
  • Peak YoY movement for Current Assets: soared 65.4% in 2024, then dropped 5.48% in 2025.
  • A 5-year view of Current Assets shows it stood at $3.2 billion in 2021, then dropped by 2.67% to $3.1 billion in 2022, then skyrocketed by 30.36% to $4.0 billion in 2023, then skyrocketed by 55.74% to $6.3 billion in 2024, then rose by 7.22% to $6.7 billion in 2025.
  • Per Business Quant database, its latest 3 readings for Current Assets were $6.7 billion in Q4 2025, $6.4 billion in Q3 2025, and $6.6 billion in Q2 2025.